TCL Archive FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity. September 29, 2000
TCL Archive In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief January 6, 1995
TCL Archive Voluntary Organizations: ACS to consider targeting Research In Prostate Cancer November 1, 1996
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
